UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 229

Sortiert nach

Cannabinoid CB₂ receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (46), p.E5007-E5015

2014

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB 1 and CB 2 receptor mechanisms underlie cannabis reward and aversion in rats

British journal of pharmacology, 2019-05, Vol.176 (9), p.1268-1281

2019

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol inhibits sucrose self‐administration by CB1 and CB2 receptor mechanisms in rodents

Addiction biology, 2020-07, Vol.25 (4), p.e12783-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors

British journal of pharmacology, 2020-04, Vol.177 (8), p.1865-1880

2020

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats

British journal of pharmacology, 2019-05, Vol.176 (9), p.1268-1281

2019

Link zum Volltext

Verfügbarkeit prüfen

β‐Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents

British journal of pharmacology, 2020-05, Vol.177 (9), p.2058-2072

2020

Link zum Volltext

Verfügbarkeit prüfen

Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects

Neuropsychopharmacology (New York, N.Y.), 2019-07, Vol.44 (8), p.1415-1424

2019

Link zum Volltext

Verfügbarkeit prüfen

Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice

Nature neuroscience, 2011-07, Vol.14 (9), p.1160-1166

2011

Link zum Volltext

Verfügbarkeit prüfen

(±)VK4‐40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents

British journal of pharmacology, 2020-10, Vol.177 (20), p.4796-4807

2020

Link zum Volltext

Verfügbarkeit prüfen

Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder

Neuropsychopharmacology (New York, N.Y.), 2021-03, Vol.46 (4), p.860-870

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats

Addiction biology, 2017-05, Vol.22 (3), p.752-765

2017

Link zum Volltext

Verfügbarkeit prüfen

Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches

Molecular psychiatry, 2022-04, Vol.27 (4), p.2171-2181

2022

Link zum Volltext

Verfügbarkeit prüfen

Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice

Addiction biology, 2021-07, Vol.26 (4), p.e13005-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist

Proceedings of the National Academy of Sciences - PNAS, 2018-11, Vol.115 (45), p.11597-11602

2018

Link zum Volltext

Verfügbarkeit prüfen

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders

Neuropsychopharmacology (New York, N.Y.), 2019-07, Vol.44 (8), p.1435-1444

2019

Link zum Volltext

Verfügbarkeit prüfen

CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice

Scientific reports, 2017-09, Vol.7 (1), p.1-15, Article 12315

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice

Behavioural brain research, 2021-10, Vol.415, p.113506-113506, Article 113506

2021

Link zum Volltext

Verfügbarkeit prüfen

Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions

Neuropsychopharmacology (New York, N.Y.), 2020-08, Vol.45 (9), p.1518-1526

2020

Link zum Volltext

Verfügbarkeit prüfen

mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism

Scientific reports, 2018-02, Vol.8 (1), p.3686-14, Article 3686

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice

Proceedings of the National Academy of Sciences - PNAS, 2018-12, Vol.115 (49), p.E11532-E11541

2018

Link zum Volltext

Verfügbarkeit prüfen

Increased vulnerability to cocaine in mice lacking dopamine D₃ receptors

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17675-17680

2012

Link zum Volltext

Verfügbarkeit prüfen

Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats

Neuropsychopharmacology (New York, N.Y.), 2018-12, Vol.43 (13), p.2615-2626

2018

Link zum Volltext

Verfügbarkeit prüfen

GPR55 is expressed in glutamate neurons and functionally modulates drug taking and seeking in rats and mice

Translational psychiatry, 2024-02, Vol.14 (1), p.101-101

2024

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms

Neuropharmacology, 2020-05, Vol.167, p.107740-107740, Article 107740

2020

Link zum Volltext

Verfügbarkeit prüfen

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

Frontiers in pharmacology, 2021-09, Vol.12, p.722476-722476

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(214)

Publikationsform

Artikel
(224)
Tagungsberichte
(5)

Sprache

Englisch
(203)
Chinesisch
(30)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cannabinoid CB₂ receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

Cannabinoid CB 1 and CB 2 receptor mechanisms underlie cannabis reward and aversion in rats

Cannabidiol inhibits sucrose self‐administration by CB1 and CB2 receptor mechanisms in rodents

Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors

Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats

β‐Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents

Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects

Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice

(±)VK4‐40, a novel dopamine D3 receptor partial agonist, attenuates cocaine reward and relapse in rodents

Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder

Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats

Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approaches

Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice

Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist

Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders

CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice

Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice

Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions

mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism

Genetic deletion of vesicular glutamate transporter in dopamine neurons increases vulnerability to MPTP-induced neurotoxicity in mice

Increased vulnerability to cocaine in mice lacking dopamine D₃ receptors

Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats

GPR55 is expressed in glutamate neurons and functionally modulates drug taking and seeking in rats and mice

Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

Suchergebnisse filtern